Thyroid disorders (TD) are the second most common endocrine disorders seen in pregnancy. Many physiological changes in pregnancy lead to hypothyroidism in pregnancy. Hypothyroid in pregnancy is associated with many adverse maternal and fetal outcomes. Objective of this study was to find the prevalence of TD in pregnancy in Nepal Medical College Teaching Hospital (NMCTH), Antithyroid Peroxidase Antibody (TPO-Ab) positive cases with hypothyroidism and to evaluate maternal fetal outcome in hypothyroid pregnancies. This was a prospective hospital based observational study. The study was done in Department of Obstetrics and Gynecology, NMCTH from August 2018 to July 2019. Among 420 pregnant ladies 71.0% were euthyroid, 25.7% were hypothyroid (25.2% of subclinical and 0.5% overt), 3.3% were hyperthyroid (0.7% of overt) and 6.4% were TPO-Ab positive with hypothyroidism. Inspite of treatment, Gestational hypertention, Pre-eclampsea and LSCS is significantly high in hypothyroid pregnancy than euthyroid pregnancy. High prevalence of hypothyroidism in this study necessitates universal screening of TD at first trimester of pregnancy.
INTRODUCTION
Thyroid disorders (TD) are the second most common endocrine disorders seen in pregnancy. TD is known to be associated with adverse maternal and fetal outcomes and is often overlooked in pregnant women because of nonspecific symptoms and hyper-metabolic state of pregnancy. 1 Pregnancy is associated with many physiological changes which lead to hypothyroidism. Pregnancy is a state of relative iodine deficiency because of increase renal loss and transfer of iodine to developing fetus. High estrogen level in pregnancy causes increased level of thyroxine-binding globulin (TBG). Serum thyrotropin level in early pregnancy decreases because of thyroid stimulation from the weak thyroid stimulating hormone (TSH), effects of human chorionic gonadotrophin (HCG). It leads to increased FT4 and decreased TSH. 2 Throughout the pregnancy maternal thyroxin is transferred to fetus. 3 Maternal thyroxin is important for normal fetal brain development, especially prior to development of fetal thyroid gland. 4 Overt hypothyroidism (OH), characterized by an elevated serum TSH and subnormal FT4. Subclinical hypothyroidism (SCH), is characterized by an elevated serum TSH with normal free thyroxine (FT4). Hypothyroid in pregnancy is observed not equally in different studies. [5] [6] [7] [8] [9] The prevalence of OH in pregnancy was 2 per 1000 births. 9 OH is defined as a serum TSH level below the trimester-specific reference range with elevated levels of free T3, free T4 or both. SCH is defined as a serum TSH level below the trimester-specific reference range with normal levels of free T3 and T4.
Overt and subclinical maternal hypothyroidism in pregnancy has been associated with adverse maternal and fetal outcomes in observational studies including miscarriages, anaemia, eclampsia, pre-eclampsia, placental abnormalities, preterm labor, low birth weights, Intra uterine growth retardation (IUGR) and still birth. [10] [11] [12] [13] [14] Haddow et al, in 1999 first described reduced intelligence quotient (IQ) in babies born from hypothyroid mothers corroborating the association between hypothyroidism and increase risk of impaired neurodevelopment in the offspring. 15 There are few researches done in TD among pregnant ladies in our country. The objective of this study was to find out the prevalence of TD in pregnancy in NMCTH. It will also help to find out the prevalence of hypothyroidism (overt and subclinical) and the Antithyroid Peroxidase Antibody (TPO-Ab) positive cases among hypothyroid females.
MATERIALS AND METHODS
This was a prospective hospital based observational study. The study was done in the Department of Obstetrics and Gynecology, NMCTH, a tertiary care hospital situated in Kathmandu. This study was done over a period of one year (August 2018 to July 2019).
After approval of proposal by NMCTH Institutional
Review Committee, all women who had singleton pregnancy irrespective of age, parity and socioeconomic status were included in the study. Those with multiple gestation, who had been previously diagnosed to have thyroid abnormality and the pregnant women who were already on treatment for TD were excluded. All the pregnant ladies in their 1 st trimester and coming to Obstetrics and Gynecology were enrolled in the study. Verbal and written consent was taken from all the patients and the blood sample was sent for thyroid function test (TFT). Report was collected and was evaluated according to trimester specific reference ranges 16 which suggest that the upper limit of TSH should be 2.5mIU/L in the 1 st trimester, and 3.0mIU/L in the 2 nd and 3 rd trimesters.
In case of hypothyroidism, TPO-Ab test was done. TSH was again repeated on 2 nd and 3 rd trimester in euthyroid pregnant females. All the cases of hypothyrodism were treated. Pregnant ladies with TSH more than 4mIU/l were treated with lthyroxin dose was adjusted. If TSH was 2.5mIU/l in 1 st trimester and 3mIU/l in 2 nd and 3 rd trimester with positive anti TPO-Ab, minimum dose of lthyroxin was given and TSH was monitered every month and drug was adjusted accordingly.
Among 420 enrolled cases, 268 cases were followed up till discharge after delivery. All the data were entered and analysed by SPSS version 16. Fisher's exact test was used for data analysis. Statistical significance was considered as P value ≤ 0.05.
RESULTS
Among 420 cases, 71.0% were euthyroid, 25.7% were hypothyroid and 3.3% were hyperthyroid. Among 108 hypothyroid cases, 25.2% were SCH and 0.5% were OH. Among 3.3% hyperthyroid cases 0.7% were OH and rest were SCH. Hypothyroidism was seen in 14.5% primigravida and 11.2% multigravida. Hyperthyroidism was seen 1.4 % in primigravida and 1.9% in multigravida. Out of total number of cases, 6.4% were TPO-Ab positive ( Table 1) .
One hundred and six cases (98.1%) of hypothyroidism were diagnosed at first trimester and treated accordingly. Only two more cases of subclinical hypothyroidism were added in second trimester. In third trimester there were no new cases of hypothyroidism ( Table 2) .
All pregnant ladies with hypothyroidism and hyperthyroidism were treated after diagnosis. Complications are relatively high in hypothyroidism as compared to euthyroid patients, but statistically it was not significant. It was seen that gestational hypertention and Pre-eclampsea in hypothyroid pregnancy was significantly higher than euthyroid pregnancy.
(9.1% versus 3.0%, where p value is equal to 0.05) ( Table 3) .
LSCS is significantly higher in hypothyroids than euthyroids (48.5% versus 18.8%, p value equal to 
DISCUSSION
TD are second most common endocrine disorders in pregnancy and are associated with adverse maternal and fetal outcome in pregnancy. However, an early detection of thyroid dysfunction and treatment of mother during pregnancy improves the outcome. 17 Early detection of TD during pregnancy is possible if the patient is suggested to do thyroid function test during her first prenatal visit or soon after the pregnancy is confirmed.
The prevalence of 25.7% hypothyroidism was found to be very high in our study. It indicates the necessity of universal screening of thyroid dysfunction in our place. There were 25.2% cases of subclinical hypothyroidism and 0.5% cases of overt hypothyroidism. Higher prevalence was found in the study done in western part of Nepal which showed 13.0% of OH and 31.0% of 19 In comparison to other studies done in different part of world prevalence of hypothyroidism is very high in Nepal. Nutritional factor may be one of the causes for this as there is high prevalance of iodine deficiency hypothyroidism in Nepal. 20, 21 Sing et al showed prevalence of hypothyroidism 7.5% (n = 30), of which 6.0% were SCH and 1.5% were OH. 22 In a study done by Sahu et al, prevalence of subclinical and overt hypothyroidism in India were 6.5% and 4.6%, respectively. 23 In a study done by Jayanthy et al, the prevalence of thyroid dysfunction was 12.0%. 24 Similar finding was seen in a study done by Dieguez et al. 25 Among women with thyroid autoimmunity, hypothyroidism may occur because of the stress of pregnancy, as the ability of the thyroid to augment hormone production is compromised. In our study, we found 6.4% of total cases hypothyroidism with positive TPO-Ab. In 1994, Glinoer et al, in his study showed asymptomatic autoimmune thyroid disorders (AITD) who are euthyroid in early pregnancy carry a significant risk of developing hypothyroidism progressively during gestation. 26 Negro et al and Gayathri et al, also demonstrated similar results in their studies. 27, 28 Prevalence of hyperthyroid in pregnancy was 3.3%, out of which Overt hyperthyroidism was 0.7% and subclinical hyperthyroidism was 2.6%. This result was comparable to other studies. In the study done by Dieguez et al, they found 0.9% was of overt hyperthyroidism and 0.8% cases of subclinical hyperthyroidism. 29 Hyperthyroidism was 2.0%, 0.8% and 0.5% in the studies of Casey et al, Singh et al and Jayanthy et al respectively. 9, 22, 24 Treatment was given to all TD pregnant females at first trimester as soon as the diagnosis was made. Only two cases had normal TSH at first trimester, hypothyroidism was detected in second trimester and treated. In our study, the prevalence of abortion, anemia, IUGR, preterm labor and PPH were high in hypothyroidism in compare to euthyroid pregnant but statistically not significant, which could probably be the result of an early detection and a good thyroid control with medications. Inspite of good thyroid control with medications, pregnancy related hypertention (PIH and PET) were significantly high in overt and subclinical hypothyroid pregnant. This is similar to several other studies. [22] [23] [24] 29, 30 In a study done by Sing et al, hypothyroidism was significantly associated with preeclampsia (p = 0.0001) and IUGR (p = 0.009) and no significant increase in miscarriage, anemia, gestational diabetes (GDM), preterm labor, still birth and PPH was seen, 22 but in a study of Jayanthy et al it was seen that pre-eclampsea, GDM/DM, Preterm delivery, preterm/LBW and neonatal morbidity was significantly high in hypothyroidism in compared to euthyroid pregnancy. 24 Other maternal and fetal complications are not significantly increased in his study.
In the review article of Nazarpour et al, it was mentioned that OH was associated with abortion, anemia, pregnancy-induced hypertension, preeclampsia, placental abruption, PPH, premature birth, low birth weight, intrauterine fetal death, increased neonatal respiratory distress and infant neuro developmental dysfunction. However the adverse effect of SCH, and thyroid antibody positivity on pregnancy outcomes was not clear. 29 Manjunatha et al in his study showed significant increase in the TSH levels in pre-eclampsia than in normal pregnancy and proved thyroid disorder as one of the predisposing causes for pre-eclampsia. 30 Rate of LSCS was also significantly high in hypothyroid than in euthyroid pregnancy and cause was mostly due to fetal distress. 22, 23 Very high prevalence of hypothyroidism in pregnancy and its severe complication like gestational hypertension and pre-eclapsea, even after treatment in this study shows necessity of universal screening of TD and its management. Early antenatal visit and universal screening of TD in first trimester is important. Most of the complication can be avoided if treated on time. Studies from Nepal shows very high prevalence of hypothyroidism. 18, 19 By treating hypothyroidism in early pregnancy, we can reduce the fetal and maternal mortality and come up with excellent fetal maternal outcome.
